醫學檢驗暨生物技術學系

Medicine & Life Sciences

1. Taiwan 100%
2. Population 73%
3. Case-Control Studies 28%
4. Neoplasms 23%
5. National Health Programs 23%
6. Confidence Intervals 22%
7. Proteins 21%
8. Stroke 21%
9. Databases 21%
10. Odds Ratio 20%
11. Hepatocellular Carcinoma 20%
12. Logistic Models 17%
13. Apoptosis 17%
14. Cohort Studies 17%
15. Erectile Dysfunction 16%
16. Breast Neoplasms 16%
17. Interstitial Cystitis 15%
18. Pregnancy Outcome 15%
19. Health Insurance 14%
20. Sudden Hearing Loss 14%
21. Datasets 14%
22. Physicians 14%
23. Therapeutics 13%
24. Regression Analysis 12%
25. Urinary Calculi 11%
26. Schizophrenia 11%
27. Obstructive Sleep Apnea 11%
28. Urbanization 11%
29. Hyperlipidemias 11%
30. Sensorineural Hearing Loss 10%
31. In Vitro Techniques 10%
32. Endothelial Cells 10%
33. Comorbidity 10%
34. Asthma 10%
35. Cell Movement 10%
36. Mothers 10%
37. Rheumatoid Arthritis 10%
38. Dendritic Cells 10%
39. Genes 10%
40. Single-Chain Antibodies 10%
41. Cesarean Section 10%
42. Cell Line 9%
43. Psoriasis 9%
44. Coronary Disease 9%
45. Down-Regulation 9%
46. Growth 9%
47. Depressive Disorder 9%
48. Phosphorylation 9%
49. Nicotinic Receptors 9%
50. Open Angle Glaucoma 9%
51. Income 9%
52. Bipolar Disorder 9%
53. Interleukin-17 8%
54. Incidence 8%
55. Carcinogenesis 8%
56. Osteopontin 8%
57. Cell Proliferation 8%
58. Neoplasm Metastasis 8%
59. Glioma 8%
60. Alternative Splicing 8%
61. Cyclooxygenase 2 8%
62. Advanced Glycation End Products 8%
63. Prostatic Neoplasms 8%
64. p38 Mitogen-Activated Protein Kinases 8%
65. Hospitalization 7%
66. Climate 7%
67. Tinnitus 7%
68. Suicide 7%
69. Pneumonia 7%
70. Delivery of Health Care 7%
71. Chronic Periodontitis 7%
72. Up-Regulation 7%
73. Costs and Cost Analysis 7%
74. RNA-Binding Motifs 7%
75. Peptides 7%
76. Monocytes 7%
77. RNA-Binding Proteins 7%
78. Colorectal Neoplasms 7%
79. Cytokines 7%
80. Extracellular Signal-Regulated MAP Kinases 7%
81. Phosphotransferases 7%
82. Serum 7%
83. Hypertension 7%
84. Age Groups 7%
85. Herpes Zoster 7%
86. Lipopolysaccharides 7%
87. Nicotine 6%
88. Brown Adipocytes 6%
89. Premature Birth 6%
90. Gene Expression 6%
91. Hydroxymethylglutaryl-CoA Reductase Inhibitors 6%
92. Dementia 6%
93. Terbinafine 6%
94. Macrophages 6%
95. Macular Degeneration 6%
96. Liver Neoplasms 6%
97. Heterografts 6%
98. Nitric Oxide Synthase Type II 6%
99. Liver 6%
100. Inflammation 6%